Market Size of Europe Single-Use Medical Device Reprocessing Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 6.10 % |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Europe Single-use Medical Device Reprocessing Market Analysis
The European single-use medical device (SUD) reprocessing market is anticipated to grow at a CAGR of 6.1% during the forecast period.
The COVID-19 pandemic resulted in postponements and cancellations of non-essential and elective procedures, such as dental procedures and orthopedic surgeries, which led to a significant decline in the number of surgeries during the pandemic. This led to a significant decline in the demand for reprocessed medical devices. For instance, according to an article published by PubMed Central in January 2022, during the first COVID-19 pandemic wave, elective procedures were significantly reduced in Europe to increase critical care capacity for patients with COVID-19 and release the surgical team to support other medical areas in need, including intensive care. Hence, the pandemic significantly impacted the demand for surgical medical devices, including reprocessed devices. However, as the pandemic subsided, the market studied is expected to witness stable growth during the forecast period.
Rising clinical urgency to minimize the generation of medical waste in healthcare settings and hospitals, cost savings through reprocessing single-use devices, and regulatory pressure to reduce volume of medical waste are among the key factors driving the market growth. The lowering of the overall cost of healthcare through the reprocessing of single-use devices is also a primary factor driving this market. In Germany, reprocessing has been regulated for over a decade with a large number of hospitals showing significant cost savings. It has been strictly subjected to monitoring and surveillance by public authorities and the European Union (EU)-accredited notified body. Similarly, in the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) legalized the use and manufacture of reprocessed single-use medical devices for use. In addition, it helps insurers and hospitals for better management and reduced healthcare costs with the improvement of the healthcare system.
Furthermore, the rising number of surgeries taking place is also a major factor driving the growth of the market as it is increasing the demand for reprocessed single-use medical devices. For instance, according to the data published by NHS in 2021, an estimated 64,211 surgical procedures were recorded by the public health of Engalnd. Hence, it is expected to increase the adoption of reprocessed medical devices.
Moreover, along with cost reduction, it also results in environmental sustainability. SUD reprocessing is one of the top healthcare supply chain strategies used to reduce costs and optimize resources. The aforementioned factors such as the rising number of surgeries taking place, rising clinical urgency to minimize the generation of medical waste in healthcare settings and hospitals, and the lowering of the overall cost of healthcare through the reprocessing of single-use devices, are anticipated to contribute towards the development of market in the immediate future.
However, the potential of material alteration and cross infection with reprocessed device and preconceived notions regarding the quality of reprocessed single-use medical devices (SUDs) are the major factors that are expected to impede the growth of this market.
Europe Single-use Medical Device Reprocessing Industry Segmentation
As per the scope of the report, single-use medical device (SUD) reprocessing includes cleaning, disinfection, and sterilization, as well as testing and restoration of the technical and functional safety of the used device. Reprocessing of SUDs makes it possible for hospitals to maintain patient care quality while saving substantial amounts of money. The European single-use medical device reprocessing market is segmented by device type (class I devices and class II devices) and geography (Germany, United Kingdom, France, Italy, Spain, and the Rest of Europe). The report offers the value (in USD million) for the above segments.
| By Device Type | ||||||
| ||||||
|
| By Geography | |
| Germany | |
| United Kingdom | |
| France | |
| Italy | |
| Spain | |
| Rest of Europe |
Europe Single-Use Medical Device Reprocessing Market Size Summary
The European single-use medical device reprocessing market is poised for growth, driven by factors such as the increasing need to reduce medical waste and healthcare costs. The market experienced a temporary setback during the COVID-19 pandemic due to the postponement of elective surgeries, which reduced the demand for reprocessed devices. However, as the pandemic's impact wanes, the market is expected to stabilize and expand. Regulatory frameworks in countries like Germany and the United Kingdom have supported the reprocessing of single-use devices, highlighting the potential for cost savings and environmental sustainability. The rising number of surgeries in Europe, coupled with the urgency to minimize waste, is further propelling market growth.
In Germany, the market is bolstered by the increasing prevalence of diseases requiring surgical intervention, such as breast and colorectal cancer, and a growing geriatric population. The high rate of cesarean sections also contributes to the demand for reprocessed medical devices. Major players like Stryker Corporation, Medline Industries Inc., and Sterilmed Inc. (Johnson & Johnson) dominate the market, although the competitive landscape remains moderate. Despite challenges such as concerns over material alteration and cross-infection, the market's growth trajectory is supported by regulatory approvals and the ongoing need for cost-effective healthcare solutions.
Europe Single-Use Medical Device Reprocessing Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Cost Savings Through Reprocessing Single-use Devices
-
1.2.2 Regulatory Pressure to Reduce Volume of Medical Waste
-
-
1.3 Market Restraints
-
1.3.1 Potential of Material Alteration and Cross Infection with Reprocessed Device
-
1.3.2 Preconceived Notions Regarding the Quality of Reprocessed Single-use Medical Devices (SUDs)
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Bargaining Power of Suppliers
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD million)
-
2.1 By Device Type
-
2.1.1 Class I Devices
-
2.1.1.1 Laparoscopic Graspers
-
2.1.1.2 Scalpels
-
2.1.1.3 Tourniquet Cuffs
-
2.1.1.4 Other Class I Devices
-
-
2.1.2 Class II Devices
-
2.1.2.1 Pulse Oximeter Sensors
-
2.1.2.2 Sequential Compression Sleeves
-
2.1.2.3 Catheters and Guidewires
-
2.1.2.4 Other Class II Devices
-
-
-
2.2 By Geography
-
2.2.1 Germany
-
2.2.2 United Kingdom
-
2.2.3 France
-
2.2.4 Italy
-
2.2.5 Spain
-
2.2.6 Rest of Europe
-
-
Europe Single-Use Medical Device Reprocessing Market Size FAQs
What is the current Europe Single-Use Medical Device Reprocessing Market size?
The Europe Single-Use Medical Device Reprocessing Market is projected to register a CAGR of 6.10% during the forecast period (2024-2029)
Who are the key players in Europe Single-Use Medical Device Reprocessing Market?
Stryker Corporation, Medline Industries, Inc, Sterilmed Inc. (Johnson & Johnson), Arjo and NEScientific are the major companies operating in the Europe Single-Use Medical Device Reprocessing Market.
